Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer McKimm-Breschkin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2019
A clinical trial lacking a control groupMike Bray, Jennifer McKimm-Breschkin
JAMA|April 5, 2007
News about influenza B drug resistance that cannot be ignoredAnne Moscona, Jennifer McKimm-Breschkin
Antiviral Therapy|January 25, 2006
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 virusesFrederick Hayden, Alexander Klimov, Masato Tashiro, et al.
Cell|July 3, 2007
ER stress triggers apoptosis by activating BH3-only protein BimHamsa Puthalakath, Lorraine A O'Reilly, Priscilla Gunn, et al.
Journal of Medicinal Chemistry|March 13, 2010
Complexity in influenza virus targeted drug design: interaction with human sialidasesLeonard M G Chavas, Ryuichi Kato, Nobuhiro Suzuki, et al.
Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2019
A clinical trial lacking a control groupMike Bray, Jennifer McKimm-Breschkin
JAMA|April 5, 2007
News about influenza B drug resistance that cannot be ignoredAnne Moscona, Jennifer McKimm-Breschkin
Antiviral Therapy|January 25, 2006
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 virusesFrederick Hayden, Alexander Klimov, Masato Tashiro, et al.
Cell|July 3, 2007
ER stress triggers apoptosis by activating BH3-only protein BimHamsa Puthalakath, Lorraine A O'Reilly, Priscilla Gunn, et al.
Journal of Medicinal Chemistry|March 13, 2010
Complexity in influenza virus targeted drug design: interaction with human sialidasesLeonard M G Chavas, Ryuichi Kato, Nobuhiro Suzuki, et al.
Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.
Pageof 1